Table 1 Susceptibilities of all 5160 included strains derived from Chinese IAIs from 2012 to 2014 to 12 tested antibiotics
| Â | Percent Susceptibilities | |||
|---|---|---|---|---|
2012 | 2013 | 2014 | Sum | |
Amikacin | 87.20 | 89.16 | 86.22 | 87.53 |
Piperacillin Tazobactam | 76.77 | 81.85 | 75.75 | 78.12 |
Ampicillin Sulbactam | 18.70 | 24.72 | 23.30 | 22.24 |
Imipenem | 80.66 | 84.26 | 79.30 | 81.41 |
Ertapenem | 73.18 | 75.71 | 70.48 | 73.12 |
Cefoxitin | 50.00 | 55.52 | 52.38 | 52.64 |
Ceftazidime | 54.80 | 61.77 | 59.69 | 58.75 |
Cefepime | 43.67 | 51.92 | 51.05 | 48.88 |
Ceftriaxone | 31.25 | 36.74 | 38.66 | 35.55 |
Cefotaxime | 30.98 | 36.49 | 37.46 | 34.98 |
Levofloxacin | 49.63 | 53.90 | 55.62 | 53.05 |
Ciprofloxacin | 45.52 | 48.20 | 50.35 | 48.02 |